Cargando…

Design of Cyclic Peptide-Based Nanospheres and the Delivery of siRNA

In recent years, cyclic peptides have attracted much attention due to their chemical and enzymatic stability, low toxicity, and easy modification. In general, the self-assembled nanostructures of cyclic peptides tend to form nanotubes in a cyclic stacking manner through hydrogen bonding. However, st...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Junfeng, Zhang, Jingli, Li, Junyang, Liu, Junqiu, Guan, Shuwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602810/
https://www.ncbi.nlm.nih.gov/pubmed/36292932
http://dx.doi.org/10.3390/ijms232012071
_version_ 1784817406923767808
author Ke, Junfeng
Zhang, Jingli
Li, Junyang
Liu, Junqiu
Guan, Shuwen
author_facet Ke, Junfeng
Zhang, Jingli
Li, Junyang
Liu, Junqiu
Guan, Shuwen
author_sort Ke, Junfeng
collection PubMed
description In recent years, cyclic peptides have attracted much attention due to their chemical and enzymatic stability, low toxicity, and easy modification. In general, the self-assembled nanostructures of cyclic peptides tend to form nanotubes in a cyclic stacking manner through hydrogen bonding. However, studies exploring other assembly strategies are scarce. In this context, we proposed a new assembly strategy based on cyclic peptides with covalent self-assembly. Here, cyclic peptide-(DPDPDP) was rationally designed and used as a building block to construct new assemblies. With cyclo-(DP)(3) as the structural unit and 2,2′-diamino-N-methyldiethylamine as the linker, positively charged nanospheres ((CP)(6)NS) based on cyclo-(DP)(3) were successfully constructed by covalent self-assembly. We assessed their size and morphology by scanning electron microscopy (SEM), TEM, and DLS. (CP)(6)NS were found to have a strong positive charge, so they could bind to siRNA through electrostatic interactions. Confocal microscopy analysis and cell viability assays showed that (CP)(6)NS had high cellular internalization efficiency and low cytotoxicity. More importantly, real-time polymerase chain reaction (PCR) and flow cytometry analyses indicated that (CP)(6)NS-siRNA complexes potently inhibited gene expression and promoted tumor cell apoptosis. These results suggest that (CP)(6)NS may be a potential siRNA carrier for gene therapy.
format Online
Article
Text
id pubmed-9602810
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96028102022-10-27 Design of Cyclic Peptide-Based Nanospheres and the Delivery of siRNA Ke, Junfeng Zhang, Jingli Li, Junyang Liu, Junqiu Guan, Shuwen Int J Mol Sci Article In recent years, cyclic peptides have attracted much attention due to their chemical and enzymatic stability, low toxicity, and easy modification. In general, the self-assembled nanostructures of cyclic peptides tend to form nanotubes in a cyclic stacking manner through hydrogen bonding. However, studies exploring other assembly strategies are scarce. In this context, we proposed a new assembly strategy based on cyclic peptides with covalent self-assembly. Here, cyclic peptide-(DPDPDP) was rationally designed and used as a building block to construct new assemblies. With cyclo-(DP)(3) as the structural unit and 2,2′-diamino-N-methyldiethylamine as the linker, positively charged nanospheres ((CP)(6)NS) based on cyclo-(DP)(3) were successfully constructed by covalent self-assembly. We assessed their size and morphology by scanning electron microscopy (SEM), TEM, and DLS. (CP)(6)NS were found to have a strong positive charge, so they could bind to siRNA through electrostatic interactions. Confocal microscopy analysis and cell viability assays showed that (CP)(6)NS had high cellular internalization efficiency and low cytotoxicity. More importantly, real-time polymerase chain reaction (PCR) and flow cytometry analyses indicated that (CP)(6)NS-siRNA complexes potently inhibited gene expression and promoted tumor cell apoptosis. These results suggest that (CP)(6)NS may be a potential siRNA carrier for gene therapy. MDPI 2022-10-11 /pmc/articles/PMC9602810/ /pubmed/36292932 http://dx.doi.org/10.3390/ijms232012071 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ke, Junfeng
Zhang, Jingli
Li, Junyang
Liu, Junqiu
Guan, Shuwen
Design of Cyclic Peptide-Based Nanospheres and the Delivery of siRNA
title Design of Cyclic Peptide-Based Nanospheres and the Delivery of siRNA
title_full Design of Cyclic Peptide-Based Nanospheres and the Delivery of siRNA
title_fullStr Design of Cyclic Peptide-Based Nanospheres and the Delivery of siRNA
title_full_unstemmed Design of Cyclic Peptide-Based Nanospheres and the Delivery of siRNA
title_short Design of Cyclic Peptide-Based Nanospheres and the Delivery of siRNA
title_sort design of cyclic peptide-based nanospheres and the delivery of sirna
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602810/
https://www.ncbi.nlm.nih.gov/pubmed/36292932
http://dx.doi.org/10.3390/ijms232012071
work_keys_str_mv AT kejunfeng designofcyclicpeptidebasednanospheresandthedeliveryofsirna
AT zhangjingli designofcyclicpeptidebasednanospheresandthedeliveryofsirna
AT lijunyang designofcyclicpeptidebasednanospheresandthedeliveryofsirna
AT liujunqiu designofcyclicpeptidebasednanospheresandthedeliveryofsirna
AT guanshuwen designofcyclicpeptidebasednanospheresandthedeliveryofsirna